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Reverse pharmacological effect of loop diuretics and altered One of the major toxic effects of lithium ions is nephro-
rBSC1 expression in rats with lithium nephropathy. genic diabetes insipidus (Li nephropathy) [1]. The re-
Background. Renal urinary concentration is associated with
versibility of the disease suggests that lithium ions haveenhanced expression of rBSC1, a rat sodium cotransporter, in
certain physiological effects on tubular function [2]. Thethe thick ascending limb of Henle. Increased expression of rBSC1
was reported recently in nephrogenic diabetes insipidus induced recent identification of cell surface membrane proteins
by lithium chloride (Li nephropathy). However, the pathophys- that are involved in renal urinary concentration has shediological implication of altered rBSC1 expression has not yet
novel insights into the pathophysiology of Li nephropa-been investigated.
Methods. Li nephropathy was induced in rats by an oral ad- thy [3, 4]. Enhanced expression of a kidney-specific apical
ministration of 40 mmol lithium/kg dry food. In rats with reduced water channel in the collecting duct (AQP2) is associated
urinary osmolality to less than 300 mOsm/kg H2O, we examined with renal urinary concentration [5–8]; however, Li ne-the expression of rBSC1 mRNA and protein, plasma arginine
phropathy causes specific down-regulation of AQP2 invasopressin (AVP) and RNA expression of kidney-specific water
channel, aquaporin-2 (AQP2), of collecting ducts. Rats with collecting ducts, directly leading to defective urinary con-
Li nephropathy were treated with furosemide (3 mg/kg body centration [3].
weight), which blocks the activity of rBSC1, and changes in urine
A kidney-specific sodium cotransporter (BSC1; bu-concentration, plasma AVP, medullary accumulation of Li
metanide-sensitive cotransporter) in the thick ascendingions, and apical AQP2 expression were determined.
Results. Rats with Li nephropathy showed increased rBSC1 limb of Henle supplies NaCl for countercurrent multi-
RNA and protein expression and reduced AQP2 RNA. In these plier to concentrate urine [9, 10]. Our previous studies
rats, furosemide, which induces dilution of urine and polyuria
[11, 12] and those of Kim et al [13] have demonstratedin normal rats, resulted in a progressive and significant rise in
a high expression of rat BSC1 (rBSC1) in dehydratedurine osmolality from 167  11 (mean  SD) at baseline to
450 45 mOsm/kg H2O at three hours after administration, and animals or following arginine vasopressin (AVP) stimu-
significant oliguria. In the same rats, plasma AVP decreased lation, indicating that rBSC1 up-regulation also is associ-significantly from 5.7 to 3.0 pg/mL. In addition, recovery of
ated closely with renal urinary concentration. Kwon etapical AQP2 expression was noted in a proportion of epithelial
cells of the collecting ducts. Although Li in the renal medulla al, however, reported the presence of enhanced rBSC1
was slightly lower in rats with Li nephropathy treated with expression in rats with Li nephropathy and highly defec-
furosemide, statistical significance was not achieved. tive urinary concentration mechanisms [4]. Thus, theConclusions. Our results suggest that dehydration or high
present study was undertaken to assess the paradox ofplasma AVP results in an enhanced rBSC1 expression in Li
nephropathy, and that rBSC1 expression is closely associated rBSC1 expression in Li nephropathy.
with the adverse effects of Li ions on collecting duct function. Lithium ion (Li) entry into the renal tubular cell and
its accumulation in renal medulla occurs through sodium
1 Drs. Michimata and Fujita contributed equally to this article. transporters, which exhibit a high selectivity for Li ions
as well as Na ions [14]. rBSC1 is a major sodium supplierKey words: sodium transport, thick ascending limb of Henle, collecting
duct, water channel, furosemide, cAMP. for countercurrent multiplier and, thus, increased rBSC1
may promote transcellular Li transport and its accumula-Received for publication October 23, 2001
tion in interstitial space of renal medulla [15], possiblyand in revised form June 10, 2002
Accepted for publication September 6, 2002 influencing renal tubular function. Since loop-diuretics,
such as furosemide, inhibit the functional ability of rBSC1, 2003 by the International Society of Nephrology
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Li uptake though rBSC1 can be transiently blocked by above, and the renal medulla was separated and used to
measure Li ion in the tissue.furosemide administration [16]. Therefore, in the present
Six control rats without LiCl treatment were used forstudy, we investigated various physiological parameters
RNA and protein extraction and for immunohistochem-in a rat model of Li nephropathy before and after admin-
istry. The experimental protocol was approved by theistration of furosemide, and examined rBSC1 expression.
Ethics Committee for Animal Experimentation at To-Our results demonstrated that altered rBSC1 expression
hoku University.is involved in the pathophysiology of Li nephropathy.
Competitive PCR for rBSC1
METHODS Competitive polymerase chain reaction (PCR) analy-
Experimental protocol sis for rBSC1 was performed as described previously
[11, 17]. Briefly, a point mutation for the formation ofMale Sprague-Dawley rats weighing around 250 g were
EcoRI site was induced in the middle of a 352 bp of atreated orally with lithium chloride as described pre-
partial fragment for the kidney-specific sodium cotrans-viously [3]. Briefly, 32 rats received 40 mmol/L lithium
porter (rBSC1) cDNA. A series of diluted mimic cDNAchloride (LiCl)/kg of dry food. During the subsequent
was mixed with a constant amount of sample template11 to 13 days, rats had free access to water and were main-
cDNA of the renal outer medulla and co-amplified usingtained in a humidity- and temperature-controlled room
rBSC1 primers. PCR proceeded for 25 cycles, and thenwith a 12/12 hour light/dark cycle. Seven days after the
the products were co-incubated with EcoRI for threestart of LiCl administration, each rat was moved to an
hours at 37C. The sample and mimic cDNA were de-individual metabolic cage for urine collection. The base-
signed to produce 352 and 180 bp fragments, respectively.line urinary volume and osmolality measurements used
After agarose gel electrophoresis, the intensity of thefor further examinations are summarized in Table 1.
band in each sample and mimic cDNA was measuredWhen osmolality decreased to300 mOsm/kg H2O, kid- using a densitometer. The amount of rBSC1 mRNA inneys from six rats were removed for RNA (right kidneys)
the sample was calculated from the equivalent point (40and protein extraction (left kidneys from 3 rats) and for
mimic for rBSC1 at the equivalent point/1 g RNA).immunohistochemistry (left kidneys from 3 rats), and 14
rats were catheterized as described previously [5, 12]. Competitive PCR for AQP2
Briefly, catheters filled with heparinized (100 U/mL)
To construct a mimic cDNA, as described previously
0.9% NaCl were placed in the femoral artery and vein.
[5, 12], a pair of PCR primers was designed to frame the
Each rat was housed in a separate cage and provided major part of AQP2 cDNA (760 bp), which contained
with water containing 5% dextrose to ensure adequate SphI and SacI restriction enzyme sites in the middle of
postoperative hydration. On the following day, after the product. By deleting 180 bp between these sites, the
urine collection for one hour, a 3-mL blood sample was final PCR product was 580 bp, which was obtained and
withdrawn that was replaced with a simultaneous injec- used to mimic cDNA for competitive PCR. A series of di-
tion of an equal volume of donor rat blood. Then, each luted mimic cDNA was mixed with the same amount of
rat was injected intraperitoneally with furosemide (3 sample template cDNA (from 0.05 g RNA) from each
mg/kg body weight) or saline, and returned to its individ- part of the kidney and co-amplified using the AQP2
ual metabolic cage. Urine was collected every one hour primer set. PCR was performed using 25 cycles. Follow-
for three hours in awakened animals. Another 3-mL ing agarose gel electrophoresis, the intensity of the bands
blood sample was withdrawn from each treated rat, and in each sample and those of the mimic cDNA was mea-
then each rat was deeply anesthetized and the kidneys sured using a densitometer. The amount of AQP2 mRNA
removed. Each kidney was divided into three parts: the in the sample was calculated from the equivalent point
cortex, outer medulla, and inner medulla. Samples from (20  amount of mimic cDNA at the equivalent point/
the right kidney were homogenized in 4 mol/L guanidine 1 g RNA).
with 25 mmol/L sodium citrate and 0.7% mercaptoetha-
Western blotsnol for RNA extraction, and those from the left kidney
were homogenized in 2 mL of phosphate-buffered saline We prepared peptide-directed rabbit polyclonal anti-
(PBS), 1% triton, 1% deoxycholate, 0.1% sodium dode- bodies that specifically recognize amino acid 33-55 of
cyl sulfate (SDS), and 0.1 mmol/L phenylmethylsulfonyl rBSC1 according to Kim et al’s study [13]. The antisera
fluoride (PMSF) for protein extraction. The left kidneys to rBSC1 was affinity-purified using a column on which
of six rats (3 treated with furosemide and 3 with saline) 1 mg of the appropriate synthetic peptides were immobi-
were sliced and fixed in 95% ethanol and used for immu- lized via covalent linkage to Sepharose beads (Sepharose
nohistochemistry. The resting 12 rats with Li nephropa- 4B; Amersham Bioscience, Little Chalfont, Buckingham-
shire, UK). Immunoblotting using the specific antibodythy were treated with furosemide or saline as mentioned
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Table 1. Effects of LiCl treatment
Lithium treatment
Before After
N 20 20
Body weight g 2549 2709a
Water intake mL/24 h 4311 13637a
Urine output mL/6 h 4.21.7 20.79.2a
Urine osmolality mOsm/kg H2O 899285 19869a
Lithium intake mmol/day 0 0.650.14
Data are means  SD.
a P  0.05 vs. before lithium treatment
against rBSC1 was performed as previously described
[12, 17]. Briefly, the renal outer medulla was homoge-
nized in 2 mL of PBS, 1% triton, 1% deoxycholate, 0.1%
SDS, and 0.1 mmol/L PMSF. One hundred micrograms
of protein in each lane were loaded in Laemmli SDS-
polyacrylamide (8%) gel electrophoresis (SDS-PAGE)
and transferred to a polyvinylidene difluoride mem-
brane. The membrane was blocked for one hour and ex-
posed to antibody diluted in 2.5% milk powder/TBST
(10 mmol/L Tris-HCl, pH 8.5, 150 mmol/L NaCl, and
0.1% Tween 20) overnight at 4C and then to a second
antibody (peroxidase-linked anti-rabbit Ig) for one hour
at room temperature. After washing, antigen-antibody
complexes were visualized with a chemiluminescence
system.
Immunohistochemistry
Ethanol-fixed specimens were stained as described Fig. 1. Competitive polymerase chain reaction (PCR) of rBSC1 (A) and
previously [11]. Briefly, 4-m thick sections were reacted AQP2 (B) in controls (C) and lithium nephropathy (Li) rats. Data repre-
sent the mean  SD of 6 determinations in each condition (*P  0.05).for one hour with immune serum diluted 1:100 anti-
AQP2 antibodies in 1% bovine serum albumin (BSA)
in PBS. The antibody against AQP2 protein was a kind
gift from Dr. Sei Sasaki (Second Department of Internal
in renal papilla was measured [19]. Briefly, the renalMedicine, Tokyo Medical and Dental School). Then,
medullas were separated, put in microcentrifuge tubes,sections were incubated for 30 minutes with a horserad-
and quickly weighed. The tubes were then plunged intoish peroxidase (HRP)-labeled polymer conjugated to
an 80C water bath for 60 minutes to inactivate the en-anti-rabbit immunoglobulin (Envision; Dako Corpora-
zymes. The tubes were dried in an oven at 80C for 48tion, Carpinteria, CA, USA), and the sites of HRP were
hours and reweighed after the tissue had attained com-visualized using diaminobenzidine (DAB), H2O2, and
plete dryness. Distilled water was then added and thewere analyzed with a photomicroscope.
bottles were plunged into a water bath at 80C for two
hours to facilitate extraction of the Li ions into water.Measurements of AVP
The tubes were cooled to room temperature and re-Arginine vasopressin was measured by radioimmuno-
weighed to determine the volume of the added water.assay (RIA) as described previously [18]. Briefly, AVP
After extraction the supernatant was analyzed by anwas extracted using octacasyl-silane packed in a cartridge
electrolyte analyzer (NOVA11; NOVA Biochemical,(Sep-Pak C18 cartridge; Waters Associates, Milford,
Waltham, MA, USA). The concentration of Li ions wasMA, USA) and assayed using specific antibodies to AVP
expressed per kilogram of wet tissue weight.(Mitsubishi Petrochemical, Tokyo, Japan). The recovery
rate was 72.4  6.8% (N  30).
Other measurements and statistical analysis
Measurement of Li in renal medulla Plasma and urinary osmolality was determined using an
osmometer (model 3D2; Advanced Instruments, NeedhamLithium ions in renal medulla were determined ac-
cording to a previous study in which solute accumulation Heights, MA, USA). Creatinine and urea concentrations
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Fig. 2. Immunoblotting of rBSC1. Charac-
teristics of peptide-directed rabbit polyclonal
antibodies that recognize amino acid 33-55 of
rBSC1 (A) and rBSC1 protein expression in
Li nephropathy (B). (A) Comparison among
pre-immunized serum, immunopurified anti-
body, and antibody absorption demonstrates
mature bands at approximately 130 kD only
in the lanes hybridized with immunopurified
antibody. The amounts of protein loaded are:
a, 150 g; b,125 g; c, 100 g; and d,75 g. The
intensity of the band increases proportion-
ately with the amount of protein loaded in the
lane. (B) Total protein (100 g) from control
rats or rats with Li nephropathy is loaded in
each lane.
in plasma and urine were measured by an autoanalyzer. kD appeared; the intensity of which changed according
to the amount of protein loaded in the lane (Fig. 2A).Differences between physiological and laboratory data
were examined for statistical significance using paired Hybridization with pre-immune serum (left lanes) or ab-
sorption (right lanes) of anti-rBSC1 antibody by immu-and unpaired t tests followed by the Student t test. The
results are expressed as mean  SD. A P value 0.05 nized peptide (incubation of 100 g antibody with 30 g
peptide for 24 hours at 4C) showed no labeling. Fig-was considered significant.
ure 2B represents immunoblots of rBSC1 in rats with
Li nephropathy; demonstrating that the intensity of the
RESULTS signal in rats treated with LiCl was stronger than those
Changes in urinary output and osmolality of controls.
Changes in body weight, urinary output and osmolal-
Effects of furosemide on rats with Li nephropathyity in rats with Li nephropathy are depicted in Table 1.
In rats with Li nephropathy treated with saline, hypo-There were significant increases in body weight, water
tonic urine was persistent and large changes in bodyintake urinary output and a significant decrease in uri-
weight were noted even within the first three hours (Fig. 3nary osmolality in rats with Li nephropathy, compared
and Table 2). Furosemide treatment resulted in a markedto baseline.
decrease in urinary volume, which was noted at two hours,
Changes in expression levels of rBSC1 and and a significant rise in urinary osmolality (Fig. 3). As ex-
AQP2 mRNAs pected, changes in body weight were less than those in
saline-treated rats. Furthermore, furosemide induced aThe results of competitive PCR analyses of rBSC1
significant reduction in plasma AVP concentration butin the outer medulla and AQP2 in the inner medulla are
did not alter plasma osmolality and sodium levels (Ta-demonstrated in Figure 1. rBSC1 transcripts in 1 g of
ble 2). These results indicate that the reduction of urinarytotal RNA was significantly higher in rats with Li ne-
volume induced by furosemide ameliorated (though notphropathy than in control rats. In contrast, AQP2 mRNA
was significantly lower in rats with Li nephropathy. completely) the dehydrated condition during the three-
hour observation period. A longer follow-up of six hours
Changes in expression level of rBSC1 protein revealed the reappearance of less concentrated urine
(350  119 mOsm/kg H2O) even in rats treated withCharacteristics of peptide-directed rabbit polyclonal
antibodies that recognized amino acid 33-55 of rBSC1 furosemide.
To assess the effect of furosemide on the absorptionare shown in Figure 2. When hybridized with immuno-
purified antibody, mature bands of approximately 130 of Li through rBSC1, Li ions in the renal medulla were
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Table 2. Effects of furosemide on rats with Li nephropathy
Furosemide Saline
Before After After
N 7 7 7
Change in body weight % 4.30.9 5.93.0
Plasma
Osmolality mOsm/kg H2O 2851 2882 2919
Sodium mEq/L 1391 1401 1402
Urea mg/dL 9.30.9 11.61.4 11.72.6
Creatinine mg/dL 0.50.1 0.50.1 0.40.1
AVP pg/mL 5.71.5 3.01.2a
Li in renal medulla nmol/g 2.580.67 2.290.86
Data are means  SD.
a P  0.05 vs. before
(Fig. 4B). In rats with Li nephropathy treated with furo-
semide, the staining intensity also was limited but the
signal was noted in the apical area of the cells (Fig. 4C).
DISCUSSION
Our present study confirms the previous findings of
elevated plasma AVP [20] and enhanced rBSC1 expres-
sion [4] in a rat model of Li nephropathy. We have
previously shown an up-regulation of rBSC1 under dehy-
dration conditions associated with elevation of plasma
AVP levels [11]. In this regard, Kim and coworkers dem-
onstrated that AVP directly induced an up-regulation
of this cotransporter [13]. Anai et al, who identified ele-
vated plasma AVP levels in Li nephropathy, speculated
that decreased plasma volume due to increased urinary
volume probably simulated AVP synthesis [20]. Thus,
dehydration or elevated AVP due to reduced plasma
volume is thought to physiologically promote rBSC1ex-Fig. 3. Effects of furosemide treatment in rats with Li nephropathy.
(A) Saline treatment did not change the urinary hypotonicity in rats pression in Li nephropathy.
with Li nephropathy (), while furosemide treatment resulted in a sig- In contrast to rBSC1, AQP2 RNA expression was re-nificant rise in urinary osmolality (). (B) Saline treatment of rats with
duced in our rat model of Li nephropathy. This findingLi nephropathy resulted in oliguria (), while furosemide treatment
resulted in a significant fall in urine volume (). Data are mean  SD. is similar to that reported previously by Marples et al in
*P  0.05 vs. before treatment. this disease [3]. Our present study also demonstrates that
AQP2 expression is probably impaired at a transcrip-
tional level. Since the expression levels of both AQP2
RNA and protein are reported to be associated withmeasured as shown in Table 2. Although Li levels in
dehydration or elevated AVP [5–8, 21, 22], these abnor-the renal medulla were slightly lower in rats treated with
malities in AQP2 expressions are considered to be asso-furosemide, this was not statistically significant (Table 2).
ciated directly with urinary concentrating defect in Li
Apical AQP2 expression nephropathy. Together with the observation of rBSC1
expression, our finings indicate that tubular injury in LiTo determine the mechanism(s) of altered urinary os-
nephropathy most likely is located only in the collectingmolality and of oliguria induced by furosemide in rats
duct until dehydration induces a reduction in the renalwith Li nephropathy, we examined AQP2 expression in
plasma flow.collecting duct by immunohistochemistry. In kidneys of
Sodium transporters, including rBSC1, possess a highcontrol rats, which developed dehydration in response
selectivity for Li ions as well as Na ions, and thereby al-to 24-hour water deprivation, a strong intensity signal was
low the entry of Li into the renal medulla. Dousa andnoted especially along the apical membrane (Fig. 4A). In
Barnes found a close association between plasma AVPkidneys of rats with Li nephropathy, the signal intensity
was lower in the cytoplasmic area of collecting duct cells level and medullary Li accumulation in rats with Li ne-
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Fig. 4. Immunohistochemistry of AQP2. (A) A representative example of a kidney from normal but dehydrated rat. (B) A representative example
of a kidney from a rat with Li nephropathy. (C ) A representative example of a kidney from a rat with Li nephropathy treated with furosemide.
phropathy [15]. Therefore, increased rBSC1, even though on the results of the present study, the effects of furose-
mide on Li nephropathy seem to be limited and transient.this increase might be a physiological reaction to dehy-
Apical AQP2 expression involves AQP2 synthesis anddration or to elevated plasma AVP, may promote Li ac-
its translocation to the membrane, and both of thesecumulation in renal medulla in Li nephropathy. We asked
processes are cAMP-dependent [6, 7, 24]. Impairmentwhether this rBSC1-enhanced Li accumulation plays
of AVP-dependent cAMP formation by LiCl has beenany pathophysiological role in Li nephropathy. To this
reported in human renal medulla [25] in addition to col-end, we blocked the rBSC1 function by loop diuretics,
lecting duct of the rat model of Li nephropathy [26, 27].using furosemide in rats with Li nephropathy. Interest-
Since apical staining for AQP2 protein was noted in theingly, furosemide induced urinary concentration and a
kidney of rats treated with furosemide, even a slightreduction of urine volume in rats with Li nephropathy.
reduction of medullary Li may result in the recoveryIn addition, immunohistochemical analysis showed that
of AQP2 translocation. We measured the cAMP concen-the furosemide treatment resulted in a slight recovery of
tration both in urine and whole kidney before and afterapical AQP2 expression. These present findings strongly
the furosemide treatment, and no difference was ob-suggest the rBSC1 expression influences collecting duct
served (data not shown). These findings suggest that itfunction, at least apical AQP2 expression in the renal
is difficult to detect a limited alteration of cAMP forma-medulla.
tion, which induced a slight enhancement of apical AQP2To assess the mechanism of the association between
expression and a moderate urinary concentration. There-rBSC1 expression and AQP2 expression in Li nephropa-
fore, the association between the Li accumulation inthy, Li accumulation in the renal medulla was exam-
renal medulla and cAMP formation in collecting ductsined. Li in the renal medulla, however, was not signifi-
remains to be investigated using other experimental tech-cantly lower in rats treated with furosemide in the
niques, such as in vitro microperfusion.present study and, thus, it is difficult to conclude that
In conclusion, our present study demonstrates that theLi transport by rBSC1 induced the toxicity. Li entry
dehydrated state or elevated plasma AVP results in a
into renal medulla occurs through other sodium trans-
physiological increase in rBSC1 expression in a rat model
porters [15, 23], and a part of the absorbed Li may of Li nephropathy. Increased rBSC1, in turn, is associ-
quickly return to systemic circulation. These conditions ated with a disturbed collecting duct function.
may mask the difference induced by furosemide.
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